Abstract
The effects on aggression in late adolescent male rats of acute administration (via intraperitoneal injection) of 10 or 20 mg/kg of the designer drug, benzylpiperazine (BZP), were assessed in comparison with 1 or 2 mg/kg of methamphetamine (MA). The two drugs are very similar in their behavioral and neurochemical effects. Aggression was measured with the resident/intruder test of aggression which involves recording eight forms of behavior in response to an intruder rat being placed in the resident drug-treated rat’s cage. Both drugs led to often dose- and specific drug-related changes in seven of the eight measures that were indicative of decreased (rather than increased) aggression which may have arisen from hyper-vigilance, increased activity or heightened fear/anxiety i.e., decreases in an aggressive posture, chasing and sniffing the intruder and self-grooming, accompanied by increases in adopting an alert position, rearing on hind legs and avoiding the intruder. It was concluded that acute treatment with neither MA nor BZP increased aggression. As revealed in earlier research with adult rats, both drugs proved to be remarkably similar in their overall behavioral effects.
Keywords: Anxiety, aggression, benzylpiperazine, methamphetamine, rat, resident/intruder test.
Current Psychopharmacology
Title:Acute Methamphetamine and Benzylpiperazine Decrease Aggression- Related Behavior in Late Adolescent Male Rats
Volume: 2
Author(s): Hamish N.L. Johnson and Robert N. Hughes
Affiliation:
Keywords: Anxiety, aggression, benzylpiperazine, methamphetamine, rat, resident/intruder test.
Abstract: The effects on aggression in late adolescent male rats of acute administration (via intraperitoneal injection) of 10 or 20 mg/kg of the designer drug, benzylpiperazine (BZP), were assessed in comparison with 1 or 2 mg/kg of methamphetamine (MA). The two drugs are very similar in their behavioral and neurochemical effects. Aggression was measured with the resident/intruder test of aggression which involves recording eight forms of behavior in response to an intruder rat being placed in the resident drug-treated rat’s cage. Both drugs led to often dose- and specific drug-related changes in seven of the eight measures that were indicative of decreased (rather than increased) aggression which may have arisen from hyper-vigilance, increased activity or heightened fear/anxiety i.e., decreases in an aggressive posture, chasing and sniffing the intruder and self-grooming, accompanied by increases in adopting an alert position, rearing on hind legs and avoiding the intruder. It was concluded that acute treatment with neither MA nor BZP increased aggression. As revealed in earlier research with adult rats, both drugs proved to be remarkably similar in their overall behavioral effects.
Export Options
About this article
Cite this article as:
Johnson N.L. Hamish and Hughes N. Robert, Acute Methamphetamine and Benzylpiperazine Decrease Aggression- Related Behavior in Late Adolescent Male Rats, Current Psychopharmacology 2013; 2 (3) . https://dx.doi.org/10.2174/22115560113020990003
DOI https://dx.doi.org/10.2174/22115560113020990003 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Metal Nanoparticles for the Treatment and Diagnosis of Neurodegenerative Brain Diseases
Current Pharmaceutical Design Cognitive Behavioral Approaches for Treating Suicidal Behavior in Adolescents
Current Psychiatry Reviews Innate Immune Surveillance in the Central Nervous System Following Legionella pneumophila Infection
CNS & Neurological Disorders - Drug Targets Editorial
Adolescent Psychiatry Endocrine Orchestration of Cardiovascular, Gastrointestinal and Hypothalamic Control
Current Medicinal Chemistry DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
CNS & Neurological Disorders - Drug Targets Adenosine Myocardial Perfusion Imaging
Current Medical Imaging Overcoming Cell Death and Tau Phosphorylation Mediated by PI3KInhibition: A Cell Assay to Measure Neuroprotection
CNS & Neurological Disorders - Drug Targets Meet Our Regional Editor
Current Bioactive Compounds Pharmacotherapy of bipolar II disorder during and after pregnancy
Current Drug Safety Strict Adherence to Guidelines in Decision Making for Coronary Angiography in Patients Who have Survived a Q Wave Myocardial Infarction; 2-Year Outcome in a Greek Population
Vascular Disease Prevention (Discontinued) Logical Design of Medical Chaperone for Prion Diseases
Current Topics in Medicinal Chemistry Serum Vitamin E (α-Tocopherol) Estimation: A Potential Biomarker of Antioxidant Status Evaluation on Heavy Metal Toxicities
Recent Patents on Biomarkers VIP and Drug Design
Current Pharmaceutical Design Maintenance of Gastrointestinal Glucose Homeostasis by the Gut-Brain Axis
Current Protein & Peptide Science Editorial (Thematic Issue: Impact of Early Life Stress on Psychiatric Disorders: Searching New Biomarkers and Innovative Pharmacological Targets)
Current Pharmaceutical Design Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges
Current Drug Targets A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member:
Current Molecular Pharmacology